ZYME
Zymeworks to Present Preclinical Data on ZW1528 at the American Thoracic Society Annual Meeting
Monday, March 31, 2025 BiopharmaWatch Research 1 min read Key Takeaway: Zymeworks to Present Preclinical Data on ZW1528 at the American Thoracic Society Annual Meeting
Price reaction · baseline $12.37 (2025-03-28 close) · clean, no other ZYME news in the window
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+23%
120-day peak, hindsight
Typical move
5.4%
average across 7 past catalysts
Cash runway
~35 mo
Minimal dilution risk
Lead asset
ZW49
Phase 1 · HER2-expressing Cancers
Full Press Release Details
Zymeworks to Present Preclinical Data on ZW1528 at the American Thoracic Society Annual Meeting.